Toll-like receptor-4 and vascular inflammation in diabetes: Editorial

Cytokine

Volumn 55, Issue 3, 2011, Pages 446-447

  Jain, Sushil K ^a   Rains, Justin L ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; FIBRINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; GENE EXPRESSION REGULATION; HUMAN; IMMUNE RESPONSE GENE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 4 GENE; VASCULITIS;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; MALE; TOLL-LIKE RECEPTOR 4;

EID: 79960889391     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.05.009     Document Type: Article

References (22)

1. Lloyd C.E., Kuller L.H., Ellis D., Becker D.J., Wing R.R., Orchard T.J. Coronary artery disease in IDDM: gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996, 16:720-726.
2. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American heart association. Circulation 1999, 100:1134-1146.
3. Devaraj S., Glaser N., Griffen S., Wang-Polagruto J., Miguelino E., Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006, 55:774-779.
4. Jain S.K., Kannan K., Lim G., Matthews-Greer J., McVie R., Bocchini J.A. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 2003, 26:2139-2143.
5. Jain S.K., Kannan K., Lim G., McVie R., Bocchini J.A. Hyperketonemia increases tumor necrosis factor-{alpha} secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency. Diabetes 2002, 51:2287-2293.
6. Targher G., Bertolini L., Zoppini G., Zenari L., Falezza G. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in type 1 diabetic patients without clinically manifest macroangiopathy. Diabetic Med 2005, 22:999-1004.
7. Devaraj S., Dasu M., Park S., Jialal I. Increased levels of ligands of toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 2009, 52:1665-1668.
8. Devaraj S., Dasu M.R., Rockwood J., Winter W., Griffen S.C., Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008, 93:578-583.
9. Barton G.M., Kagan J.C. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 2009, 9:535-542.
10. Drexler S.K., Foxwell B.M. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010, 42:506-518.
11. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4. J Biol Chem 2001, 276:16683-16689.
12. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits toll-like receptor 2 dimerized with toll-like receptor 6 or 1. J Biol Chem 2004, 279:16971-16979.
13. Michelsen K.S., Wong M.H., Shah P.K., Zhang W., Yano J., Doherty T.M., et al. Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101:10679-10684.
14. Yamashita T., Freigang S., Eberle C., Pattison J., Gupta S., Napoli C., et al. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res 2006, 99:E51-64.
15. Rice J.B., Stoll L.L., Li W.-G., Denning G.M., Weydert J., Charipar E., et al. Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. Arterioscler Thromb Vasc Biol 2003, 23:1576-1582.
16. Mohammad M.K., Morran M., Slotterbeck B., Leaman D.W., Sun Y., Grafenstein H.V., et al. Dysregulated toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 2006, 18:1101-1113.
17. Devaraj S, Tobias P, Jialal I. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 2011. doi:10.1016/j.cyto.2011.03.023. doi:10.1016/j.cyto.2011.03.023.
18. Dasu M.R., Devaraj S., Zhao L., Hwang D.H., Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008, 57:3090-3098.
19. Ameziane N., Beillat T., Verpillat P., Chollet-Martin S., Aumont M.-C., Seknadji P., et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003, 23:e61-4.
20. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002, 347:185-192.
21. Devaraj S., Jialal I., Yun J.-M., Bremer A. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism 2011, 60:256-259.
22. Rains J.L., Jain S.K. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011, 50:567-575.